Press Release May 30, 2022
Innovative Medicines Canada welcomes new Board Chair, Alok Kanti
Ottawa, May 30, 2022 – Innovative Medicines Canada (IMC) is pleased to announce Alok Kanti, President and Chief Executive Officer of […]
All News
Our news library that includes all press releases and industry related news.
Filter by
Press Release May 25, 2022
Health Research Foundation Now Accepting Nominations for its Medal of Honour
Nominate a remarkable individual who is making a difference in health sciences by June 22. OTTAWA, ON, May 25, 2022 […]
Press Release May 12, 2022
Innovative Medicines Canada applauds Quebec’s new Life Sciences Strategy
Ottawa, May 12, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, welcomes Quebec’s new Life […]
Press Release April 28, 2022
Innovative Medicines Canada welcomes the Ontario budget’s investments in life sciences and innovation
Ottawa, April 28, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement in response to […]
Press Release April 20, 2022
Innovative Medicines Canada Statement on the PMPRB Regulations Announcement
Ottawa, April 20, 2022 – Innovative Medicines Canada (IMC), the association representing Canada’s research-based pharmaceutical sector, issued the following statement […]
Press Release March 31, 2022
PMPRB continues to ignore the value of innovative medicines for Canadians
Ottawa, March 31, 2022 – Innovative Medicines Canada (IMC) is disappointed by the latest Patented Medicine Prices Review Board (PMPRB) […]
Featured News September 21, 2021
Innovative Medicines Canada congratulates Prime Minister Justin Trudeau on his re-election
IMC welcomes Canada’s 44th Parliament […]
Featured News April 12, 2021
New Statistics Canada research shows the full extent of the innovative pharmaceutical sector’s investments in Canada
Statistics Canada’s new report […]
Featured News January 13, 2021
New IMC report shows impact of chronic disease and increased claims on private drug plans
Growth in chronic disease and increased drug claims […]
Featured News December 30, 2020
Delaying implementation of PMPRB’s Regulations an opportunity to protect patient access to medicines and vaccines
We support Health Canada’s decision to delay […]
Featured News November 25, 2020
Statement: COVID-19 Vaccine Manufacturing Capacity
IMC issued the following statement today in response to questions […]
Featured News June 29, 2020
IMC responds to Federal Court decision regarding PMPRB regulatory changes
We have just received the Federal Court’s decision […]